Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association of dopamine receptor D1 (DRD1) polymorphisms with risperidone treatment response in Chinese schizophrenia patients.

Neuroscience letters - 1 Jan 2015

Huo Ran, Wei Zhiyun, Xiong Yuyu, Jiang Jie, Liu Yichen, Yan Yucai, Shi Jiajun, Li Wenqiang, Cui Donghong, Xing Qinghe, He Lin, Qin Shengying

Abstract excerpt

Evidence suggests that dopamine receptor D1 (DRD1) may be involved in the pathophysiology of schizophrenia and the pharmacodynamics of antipsychotics. We conducted a comprehensive pharmacogenomics study to investigate the association of genetic polymorphisms in DRD1 with treatment response to risperidone. Two independent cohorts of Han Chinese schizophrenic patients (n = 185) from two different geographic areas...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antipsychotic Agents
Share to Asian People

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DRD1 gene

Share to Genetic Association Studies

Share to Polymorphism, Single Nucleotide

Share to Receptors, Dopamine D1

Share to Risperidone

Share to Schizophrenia

Source

Identifiers

PMID: 25179995
DOI: 10.1016/j.neulet.2014.08.041

Genes

DRD1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association of dopamine receptor D1 (DRD1) polymorphisms with risperidone treatment response in Chinese schizophrenia patients.PMID 25179995Read ↗

Association between dopamine receptor gene polymorphisms and effects of risperidone treatment: A systematic review and meta-analysis.Semantic proximity Read ↗

The relationship between the therapeutic response to risperidone and the dopamine D2 receptor polymorphism in Chinese schizophrenia patients.Semantic proximity Read ↗

Dopamine transporter polymorphisms and risperidone response in Chinese schizophrenia patients: an association study.Semantic proximity Read ↗

Combined study of genetic and epigenetic biomarker risperidone treatment efficacy in Chinese Han schizophrenia patients.Semantic proximity Read ↗

Effects of the dopamine D3 receptor (DRD3) gene polymorphisms on risperidone response: a pharmacogenetic study.Semantic proximity Read ↗

Association studies of genomic variants with treatment response to risperidone, clozapine, quetiapine and chlorpromazine in the Chinese Han population.Semantic proximity Read ↗

Association of a Schizophrenia Risk Variant at the DRD2 Locus With Antipsychotic Treatment Response in First-Episode Psychosis.Semantic proximity Read ↗

Meta-analysis of dopamine receptor D1 rs4532 polymorphism and susceptibility to antipsychotic treatment response.Semantic proximity Read ↗

DRD1 rs4532 polymorphism: a potential pharmacogenomic marker for treatment response to antipsychotic drugs.Semantic proximity Read ↗

Pharmacogenetics analysis of serotonin receptor gene variants and clinical response to risperidone in Han Chinese schizophrenic patients.Semantic proximity Read ↗

Genetic polymorphisms in dopaminergic system and treatment-resistant schizophrenia.Semantic proximity Read ↗

Effects of dopamine D2 receptor Ser311Cys polymorphism and clinical factors on risperidone efficacy for positive and negative symptoms and social function.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.